CD Biosynsis offers specialized Synechococcus spp. Multi-Gene Knockout Strain Construction services, providing a high-efficiency platform for the comprehensive metabolic remodeling of these vital photosynthetic cyanobacteria. In the complex regulatory landscape of Synechococcus, many metabolic pathways—such as those involved in glycogen storage, phycobilisome regulation, and carbon partitioning—are governed by redundant gene families or competitive enzymatic nodes. Our service leverages multiplexed CRISPR-Cas9 and Cas12a (Cpf1) systems to bypass these redundancies, enabling the rapid generation of poly-mutant chassis strains optimized for industrial bioproduction.
Constructing multi-gene knockout strains in Synechococcus requires navigating the unique challenge of polyploidy, where a single cell contains multiple copies of its chromosome. Our platform addresses this through "accelerated segregation" techniques, utilizing the CRISPR nuclease to provide active selective pressure against wild-type alleles at all targeted loci simultaneously. By integrating poly-cistronic gRNA arrays and "scarless" editing protocols, we deliver stable, homozygous strains that are stripped of non-essential metabolic drains, providing an ideal foundation for the solar-driven synthesis of biofuels, bioplastics, and specialty chemicals.
Get a QuoteIn Synechococcus species like S. elongatus PCC 7942 and S. sp. PCC 7002, achieving a significant shift in metabolic flux often requires the disruption of multiple genes. For instance, redirecting carbon from natural storage products toward non-native molecules usually requires the simultaneous knockout of glycogen synthase (glgA) and other competing sinks. Our multiplexed platform allows for the targeting of 2 to 5 genes in a single transformation event, significantly reducing the development timeline compared to sequential homologous recombination.
Our strategic focus is on the creation of "Minimal Photosynthetic Chassis." By systematically knocking out genes that are non-essential for lab-scale growth but consume significant energy—such as certain components of the light-harvesting complex or secondary regulatory circuits—we can enhance the specific productivity of the engineered strain. We use predictive Flux Balance Analysis (FBA) to identify the optimal combination of knockout targets, ensuring that the cumulative disruption maximizes carbon redirection toward your target biosynthetic pathway without compromising the cell's photosynthetic integrity or stress resilience.
We provide a range of multiplexing tools tailored to the high transcriptional activity and polyploid nature of Synechococcus.
gRNA Arrays
Expression of multiple gRNAs from a single promoter using tRNA or Csy4 processing systems to ensure balanced repression and cutting at multiple nodes.
Cas12a Advantage
Utilizing the inherent RNA-processing capability of Cas12a to process its own short CRISPR arrays, simplifying the construction of multi-target vectors.
Marker Recycling
Application of recombinase systems (e.g., Cre-Lox) or CRISPR-mediated selection to remove markers after each round of modification, allowing for infinite stacked edits.
Episomal Curing
Using replicative plasmids to express CRISPR tools that can be "cured" or removed from the strain once the modifications are homozygous and stable.
Sink Elimination
Simultaneous knockout of glycogen biosynthesis and PHA production to force carbon flux into non-native biosynthetic routes.
Antennae Reduction
Targeting multiple genes in the phycobilisome complex to reduce cell self-shading and improve light distribution in high-density cultures.
Our systematic pipeline ensures the precision of genetic modifications and the homozygous status of every targeted chromosome.
1. Computational Design
2. Build & Preparation
3. Transformation & Segregation
4. Multi-Allelic Verification
Bioinformatic mapping of all target genes and paralogs. Design of optimized gRNA arrays and codon-optimization of Cas9/Cas12a for the cyanobacterial host.
Synthesis of multiplex CRISPR vectors (integrative or replicative). Preparation of competent Synechococcus cells or conjugation donor strains.
Genotyping: Comprehensive verification of all targeted loci via multi-locus PCR and Next-Generation Sequencing (NGS). Phenotypic Characterization: Assessment of biomass growth and target bioproduct titers. Delivery of cryopreserved strains.
Rapid Homozygosity
Active CRISPR selection forces the rapid elimination of wild-type alleles across all chromosome copies, cutting segregation time by 70%.
Markerless Flexibility
Advanced scarless editing techniques allow for the construction of complex, multi-gene production strains without the limitations of selection marker availability.
Pathway-Scale Rewiring
Ability to simultaneously inactivate multiple competitive pathways, providing a high-performance chassis for systems biology and biomanufacturing.
NGS-Verified Accuracy
Every poly-mutant strain is delivered with full NGS verification of all modified sites, ensuring 100% genetic purity and definition.
1. How many genes can be knocked out in a single step?
Using poly-cistronic gRNA arrays, we typically target 2 to 4 genes simultaneously. For more extensive modifications, we utilize iterative rounds of scarless editing.
2. How do you ensure all genome copies are edited in polyploid strains?
We utilize the CRISPR nuclease to actively target and eliminate chromosomes that still contain the wild-type sequence. This forces the cell to replicate only the edited versions, achieving homozygosity quickly.
3. Is there a growth penalty for knocking out multiple genes?
This depends on the targets. We use metabolic modeling (FBA) to select target combinations that maximize productivity while maintaining industrial-level growth vigor.
4. Which Synechococcus strains are compatible with multiplexing?
We have optimized protocols for S. elongatus PCC 7942 and S. sp. PCC 7002, and can adapt these for other marine or industrial isolates.
5. How do you handle gene families with high sequence similarity?
We design specific gRNAs targeting unique regions to isolate individual family members or target conserved sequences to disrupt the entire family at once.
6. Are the multi-gene knockout strains marker-free?
Yes, by using transient CRISPR systems or marker excision (like sacB or Cre-Lox), we can provide "clean" strains free of antibiotic resistance genes.
7. Can you combine multi-gene knockouts with pathway overexpressions?
Absolutely. We often integrate new biosynthetic pathways into "Neutral Sites" while simultaneously knocking out competitive endogenous genes.
8. What is the typical turnaround time for a triple-knockout project?
A simultaneous triple-knockout project from design to homozygous strain delivery typically takes 12 to 16 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.